Predisposition to hereditary breast cancer has been attributed in part
to inherited mutations in the BRCA2 gene. The large protein it encode
s is still poorly characterized with respect to functions. We have pre
viously shown that BRCA2 has transcriptional activation potential conf
erred by its amino-terminal third exon, Here, me show that BRCA2 inter
acts with a transcriptional co-activator protein, P/CAF, which possess
es histone acetyltransferase activity, The interaction with P/CAF is d
emonstrated in vitro as well as in vivo and is shown to be mediated by
residues 290-453 of BRCA2, Consistent with the binding to an acetyltr
ansferase, BRCA2 is shown to associate with acetyltransferase activity
in nuclear extracts. Contrary to a recent report, we find no evidence
in support of an intrinsic HAT activity in BRCA2 amino-terminus. Our
results further substantiate the notion that BRCA2 has transcriptional
activation function and suggest that one mechanism by which BRCA2 reg
ulates transcription may be through the recruitment of histone-modifyi
ng activity of the P/CAF co-activator.